Complete Health Indicator Report of Incidence of Non-Hodgkin Lymphoma
Definition
Incidence rate of non-Hodgkin lymphoma for a defined population in a specified time interval. Rates are age-adjusted to the 2000 U.S. Standard Population. Rates are per 100,000 population.Numerator
Number of new cases of non-Hodgkin lymphoma among a defined population in a specified time interval.Denominator
Defined population in a specified time interval.Why Is This Important?
In New Jersey, 1,317 males and 1096 females were diagnosed with non-Hodgkin lymphoma during 2018.How Are We Doing?
Between 1990 and 2018, the age-adjusted incidence rate of non-Hodgkin lymphoma in New Jersey males increased from 22.3 cases per 100,000 to about 26.9 cases per 100,000. Among New Jersey females, the incidence rates increased from 14.7 cases per 100,000 in 1990 to 18.2 cases per 100,000 in 2018. The lifetime risk of developing non-Hodgkin lymphoma is 1 in 41 for men and 1 in 52 for women.What Is Being Done?
A Comprehensive Cancer Control Plan was developed by the Task Force on Cancer Prevention, Early Detection and Treatment in New Jersey which aims to reduce the incidence, illness and death due to cancer among New Jersey residents. [https://www.cdc.gov/cancer/ncccp/ccc_plans.htm]Available Services
The New Jersey Department of Health (NJDOH) has many programs and partnerships related to cancer data and information, cancer resources and cancer prevention. Cancer Epidemiology Services: [https://nj.gov/health/ces/] Interactive New Jersey cancer incidence and mortality data, as well as numerous publications, are available through the NJDOH website for cancer statistics and mapping. [https://www.nj.gov/health/ces/cancer-researchers/cancer-data/index.shtml] Office of Cancer Control and Prevention: [https://www.nj.gov/health/ces/public/resources/occp.shtml] NJ Cancer Education and Early Detection (NJCEED): [https://www.nj.gov/health/ces/public/resources/njceed.shtml] NJ Commission on Cancer Research: [https://www.nj.gov/health/ces/cancer-researchers/njccr.shtml]Data Tables
NJ Age-Adjusted Non-Hodgkin Lymphoma Incidence, by Year and Sex, 1990 - 2018
Sex | Year | Age-Adjusted Rate per 100,000 | Lower Limit | Upper Limit | Numer- ator | |
---|---|---|---|---|---|---|
Record Count: 58 | ||||||
Male | 1990 | 22.3 | 20.6 | 24.0 | 757 | |
Male | 1991 | 22.2 | 20.6 | 23.9 | 771 | |
Male | 1992 | 22.5 | 20.9 | 24.2 | 787 | |
Male | 1993 | 23.2 | 21.6 | 24.9 | 815 | |
Male | 1994 | 24.4 | 22.8 | 26.1 | 864 | |
Male | 1995 | 25.6 | 24.0 | 27.4 | 923 | |
Male | 1996 | 26.9 | 25.2 | 28.7 | 963 | |
Male | 1997 | 25.5 | 23.8 | 27.2 | 927 | |
Male | 1998 | 27.7 | 26.0 | 29.5 | 1,028 | |
Male | 1999 | 26.1 | 24.5 | 27.8 | 978 | |
Male | 2000 | 25.5 | 23.9 | 27.1 | 964 | |
Male | 2001 | 28.3 | 26.7 | 30.1 | 1,082 | |
Male | 2002 | 26.0 | 24.4 | 27.6 | 997 | |
Male | 2003 | 26.3 | 24.7 | 28.0 | 1,032 | |
Male | 2004 | 26.0 | 24.5 | 27.7 | 1,036 | |
Male | 2005 | 26.2 | 24.6 | 27.9 | 1,051 | |
Male | 2006 | 26.9 | 25.3 | 28.6 | 1,090 | |
Male | 2007 | 25.9 | 24.4 | 27.6 | 1,066 | |
Male | 2008 | 26.4 | 24.9 | 28.1 | 1,104 | |
Male | 2009 | 26.1 | 24.5 | 27.7 | 1,113 | |
Male | 2010 | 25.5 | 24.0 | 27.1 | 1,086 | |
Male | 2011 | 25.5 | 24.0 | 27.1 | 1,101 | |
Male | 2012 | 26.8 | 25.3 | 28.4 | 1,182 | |
Male | 2013 | 25.9 | 24.4 | 27.4 | 1,171 | |
Male | 2014 | 25.7 | 24.2 | 27.2 | 1,176 | |
Male | 2015 | 27.5 | 25.9 | 29.1 | 1,260 | |
Male | 2016 | 26.4 | 24.9 | 27.9 | 1,233 | |
Male | 2017 | 26.0 | 24.6 | 27.6 | 1,259 | |
Male | 2018 | 26.9 | 25.5 | 28.5 | 1,317 | |
Female | 1990 | 14.7 | 13.6 | 15.9 | 656 | |
Female | 1991 | 15.5 | 14.4 | 16.8 | 698 | |
Female | 1992 | 14.9 | 13.8 | 16.1 | 684 | |
Female | 1993 | 16.5 | 15.4 | 17.8 | 761 | |
Female | 1994 | 17.0 | 15.8 | 18.3 | 794 | |
Female | 1995 | 17.4 | 16.2 | 18.6 | 814 | |
Female | 1996 | 17.8 | 16.6 | 19.0 | 844 | |
Female | 1997 | 19.7 | 18.5 | 21.0 | 946 | |
Female | 1998 | 20.1 | 18.8 | 21.4 | 979 | |
Female | 1999 | 18.4 | 17.2 | 19.7 | 910 | |
Female | 2000 | 18.9 | 17.7 | 20.2 | 934 | |
Female | 2001 | 18.7 | 17.5 | 19.9 | 937 | |
Female | 2002 | 18.1 | 17.0 | 19.3 | 919 | |
Female | 2003 | 18.3 | 17.2 | 19.6 | 934 | |
Female | 2004 | 18.3 | 17.1 | 19.5 | 941 | |
Female | 2005 | 17.6 | 16.4 | 18.8 | 909 | |
Female | 2006 | 18.5 | 17.3 | 19.7 | 959 | |
Female | 2007 | 17.9 | 16.8 | 19.1 | 947 | |
Female | 2008 | 18.5 | 17.4 | 19.7 | 983 | |
Female | 2009 | 18.2 | 17.1 | 19.4 | 978 | |
Female | 2010 | 18.2 | 17.1 | 19.4 | 1,000 | |
Female | 2011 | 18.7 | 17.6 | 19.9 | 1,033 | |
Female | 2012 | 17.4 | 16.3 | 18.6 | 979 | |
Female | 2013 | 18.2 | 17.1 | 19.4 | 1,023 | |
Female | 2014 | 18.3 | 17.2 | 19.5 | 1,043 | |
Female | 2015 | 18.8 | 17.7 | 20.0 | 1,087 | |
Female | 2016 | 18.5 | 17.4 | 19.7 | 1,087 | |
Female | 2017 | 18.2 | 17.1 | 19.4 | 1,079 | |
Female | 2018 | 18.2 | 17.1 | 19.4 | 1,096 |
Data Notes
Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified.Data Sources
- NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
- NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]
NJ Age-Adjusted Non-Hodgkin Lymphoma Incidence by County, Males, 2014-2018
County | Age-Adjusted Rate per 100,000 Males | Lower Limit | Upper Limit | Numer- ator | ||
---|---|---|---|---|---|---|
Record Count: 22 | ||||||
Atlantic | 27.6 | 23.9 | 31.8 | 210 | ||
Bergen | 27.3 | 25.3 | 29.5 | 713 | ||
Burlington | 27.0 | 24.1 | 30.1 | 345 | ||
Camden | 26.0 | 23.3 | 29.0 | 345 | ||
Cape May | 22.2 | 17.6 | 27.8 | 86 | ||
Cumberland | 25.4 | 20.6 | 30.9 | 103 | ||
Essex | 22.5 | 20.4 | 24.9 | 410 | ||
Gloucester | 27.2 | 23.5 | 31.3 | 206 | ||
Hudson | 20.5 | 18.2 | 23.1 | 303 | ||
Hunterdon | 22.2 | 17.6 | 27.8 | 89 | ||
Mercer | 28.0 | 24.6 | 31.7 | 254 | ||
Middlesex | 25.6 | 23.5 | 27.9 | 537 | ||
Monmouth | 29.5 | 26.9 | 32.3 | 514 | ||
Morris | 28.5 | 25.7 | 31.5 | 400 | ||
Ocean | 28.2 | 25.7 | 30.8 | 538 | ||
Passaic | 25.1 | 22.3 | 28.2 | 302 | ||
Salem | 22.6 | 16.1 | 31.1 | 42 | ||
Somerset | 31.1 | 27.4 | 35.1 | 274 | ||
Sussex | 28.6 | 23.3 | 34.7 | 117 | ||
Union | 25.7 | 23.1 | 28.7 | 353 | ||
Warren | 32.5 | 26.2 | 39.8 | 102 | ||
New Jersey | 26.5 | 25.8 | 27.2 | 6,245 |
Data Notes
Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.Data Sources
- NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
- NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]
NJ Age-Adjusted Non-Hodgkin Lymphoma Incidence by County, Females, 2014-2018
County | Age-Adjusted Rate per 100,000 Females | Lower Limit | Upper Limit | Numer- ator | ||
---|---|---|---|---|---|---|
Record Count: 22 | ||||||
Atlantic | 17.3 | 14.6 | 20.2 | 164 | ||
Bergen | 19.5 | 18.0 | 21.2 | 642 | ||
Burlington | 17.3 | 15.3 | 19.6 | 271 | ||
Camden | 18.3 | 16.2 | 20.6 | 303 | ||
Cape May | 16.2 | 12.4 | 21.2 | 72 | ||
Cumberland | 17.2 | 13.6 | 21.5 | 82 | ||
Essex | 15.6 | 14.0 | 17.3 | 369 | ||
Gloucester | 18.6 | 15.8 | 21.8 | 169 | ||
Hudson | 15.3 | 13.5 | 17.2 | 269 | ||
Hunterdon | 19.1 | 15.2 | 23.8 | 89 | ||
Mercer | 18.3 | 15.8 | 21.0 | 214 | ||
Middlesex | 19.0 | 17.4 | 20.9 | 487 | ||
Monmouth | 20.9 | 19.0 | 23.0 | 468 | ||
Morris | 20.4 | 18.2 | 22.8 | 340 | ||
Ocean | 18.0 | 16.3 | 19.9 | 460 | ||
Passaic | 17.6 | 15.5 | 19.9 | 265 | ||
Salem | 17.3 | 11.9 | 24.4 | 38 | ||
Somerset | 19.6 | 17.0 | 22.6 | 213 | ||
Sussex | 20.3 | 16.3 | 25.1 | 95 | ||
Union | 17.6 | 15.6 | 19.8 | 301 | ||
Warren | 20.9 | 16.4 | 26.5 | 79 | ||
New Jersey | 18.4 | 17.9 | 18.9 | 5,392 |
Data Notes
Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ..., 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Number of cases (numerator) is the total count of cases in five years.Data Sources
- NJ State Cancer Registry, Nov 16, 2020 Analytic File, using NCI SEER*Stat ver. 8.3.9, [https://seer.cancer.gov/seerstat/]
- NJ population estimates as calculated by the NCI's SEER Program, released February 2021, [https://www.seer.cancer.gov/popdata/download.html]
Page Content Updated On 10/04/2021,
Published on 12/03/2021